NASDAQ:MIRO Miromatrix Medical (MIRO) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MIRO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.39▼$3.3950-Day Range$3.31▼$3.4052-Week Range$0.91▼$4.35VolumeN/AAverage Volume80,095 shsMarket Capitalization$92.95 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Miromatrix Medical alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Miromatrix Medical Stock (NASDAQ:MIRO)Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.Read More Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 MIRO Stock News HeadlinesFebruary 22, 2024 | uk.finance.yahoo.comQ4 2023 United Therapeutics Corp Earnings CallNovember 22, 2023 | benzinga.comBest Stocks to Buy Right NowApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.November 15, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24, revenue of $11.17MNovember 14, 2023 | finance.yahoo.comMiromatrix Reports Third Quarter 2023 ResultsOctober 31, 2023 | proactiveinvestors.comMiromatrix Medical climbs 225% following $140m United Therapeutics bidOctober 31, 2023 | msn.comUnited Therapeutics agrees to buy Miromatrix MedicalOctober 31, 2023 | marketwatch.comMiromatrix Medical Shares Triple After United Therapeutics OfferApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.October 30, 2023 | startribune.comEden Prairie biotech company Miromatrix Medical sells for $91MOctober 30, 2023 | msn.comUnited Therapeutics to buy Miromatrix Medical for $3.25 per shareOctober 30, 2023 | investorplace.comWhy Is Miromatrix Medical (MIRO) Stock Up 235% Today?October 11, 2023 | finance.yahoo.comMiromatrix to Present at the 2023 ISODP Organ Donation CongressOctober 5, 2023 | finance.yahoo.comMiromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the MesaSeptember 10, 2023 | finance.yahoo.comSeveral Insiders Invested In Miromatrix Medical Flagging Positive NewsSeptember 5, 2023 | finance.yahoo.comMiromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics WorkshopAugust 21, 2023 | finance.yahoo.comMiromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finanznachrichten.deMiromatrix Medical Inc.: Miromatrix Reports Second Quarter 2023 Results and Provides Corporate UpdateAugust 15, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24August 15, 2023 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Miromatrix Medical (MIRO)August 15, 2023 | finance.yahoo.comQ2 2023 Miromatrix Medical Inc Earnings CallAugust 14, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24 beats by $0.05, revenue of $8.52M beats by $8.52MAugust 14, 2023 | finance.yahoo.comMiromatrix Reports Second Quarter 2023 Results and Provides Corporate UpdateAugust 11, 2023 | benzinga.comPreview: Miromatrix Medical's EarningsAugust 10, 2023 | msn.comLab-grown ‘ghost hearts' work to solve organ transplant shortage by combining a cleaned-out pig heart with a patient’s own stem cellsJuly 25, 2023 | finance.yahoo.comMiromatrix to Report Second Quarter 2023 Financial ResultsJuly 13, 2023 | finance.yahoo.comMiromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement AwardSee More Headlines Receive MIRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:MIRO CUSIPN/A CIK1527096 Webwww.miromatrix.com Phone952-942-6000FaxN/AEmployees76Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside-11.5%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,960,000.00 Net Margins-2,861.17% Pretax Margin-2,861.17% Return on Equity-120.49% Return on Assets-90.70% Debt Debt-to-Equity Ratio0.02 Current Ratio3.46 Quick Ratio3.46 Sales & Book Value Annual Sales$958,029.00 Price / Sales97.02 Cash FlowN/A Price / Cash FlowN/A Book Value$1.25 per share Price / Book2.71Miscellaneous Outstanding Shares27,419,000Free Float25,993,000Market Cap$92.95 million OptionableOptionable Beta0.01 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Jeffrey James Ross Ph.D. (Age 47)CEO & Director Comp: $797.5kMr. James M. Douglas (Age 49)CFO & Secretary Comp: $487.5kMr. Rodrigo Mesquita P.M.P.Vice President of Manufacturing & OperationsMr. Tom EmigVice President of People & CultureKey CompetitorsNeon TherapeuticsNASDAQ:NTGNEntasis TherapeuticsNASDAQ:ETTXKinnate BiopharmaNASDAQ:KNTENGM BiopharmaceuticalsNASDAQ:NGMLianBioNASDAQ:LIANView All Competitors MIRO Stock Analysis - Frequently Asked Questions What is Miromatrix Medical's stock price target for 2024? 0 Wall Street research analysts have issued 12 month target prices for Miromatrix Medical's shares. Their MIRO share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. This suggests that the stock has a possible downside of 11.5%. View analysts price targets for MIRO or view top-rated stocks among Wall Street analysts. How were Miromatrix Medical's earnings last quarter? Miromatrix Medical Inc. (NASDAQ:MIRO) released its earnings results on Monday, November, 15th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.12. The firm earned $0.01 million during the quarter. Miromatrix Medical had a negative trailing twelve-month return on equity of 120.49% and a negative net margin of 2,861.17%. When did Miromatrix Medical IPO? Miromatrix Medical (MIRO) raised $32 million in an initial public offering on Thursday, June 24th 2021. The company issued 4,000,000 shares at a price of $7.00-$9.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO. This page (NASDAQ:MIRO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miromatrix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
